Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05932914 · ClinicalTrials.gov registry record
Liver Biopsy Following Gene Therapy For Hemophilia
A clinical trial, sponsored by St. Jude Children's Research Hospital.
- Not yet
- Registry status
- 8
- Enrollment target
NCT05932914 is a clinical trial that has not yet begun recruiting, run by St. Jude Children's Research Hospital. The registered enrollment target is 8 participants.
The verdict
NCT05932914 has not yet begun recruiting, sponsored by St. Jude Children's Research Hospital.
- NOT YET RECRUITING
- Registry status
- 8 participants
- Enrollment target
Study Summary
This observational study will obtain liver biopsy samples and evaluate the long-term effect of adeno-associated virus (AAV)-mediated gene therapy on the liver tissue in adult patients with hemophilia A or hemophilia B who have previously been treated with a factor VIII or factor IX gene-containing AAV-vector for liver-targeted gene transfer. Participants are from a cohort of patients treated with AAV-mediated gene transfer and at least 6 months after vector infusion.
Interventions
- PROCEDURE Liver Biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2026-07 |
| Est. Completion | 2030-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05932914
The ClinicalTrials.gov registry entry for NCT05932914 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Liver Biopsy is the first listed.
NCT05932914 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05932914 about?
NCT05932914 is a clinical study titled "Liver Biopsy Following Gene Therapy For Hemophilia". This observational study will obtain liver biopsy samples and evaluate the long-term effect of adeno-associated virus (AAV)-mediated gene therapy on the liver tissue in adult patients with hemophilia A or hemophilia B who have previously been treated with a factor VIII or factor IX gene-containing A...
What is the current status of trial NCT05932914?
This trial is currently not yet recruiting. The enrollment target is 8 participants. The study started on 2026-07. Estimated completion is 2030-01.
What interventions are being tested in trial NCT05932914?
The interventions under investigation include: Liver Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT05932914?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.